Will direct-acting antivirals make a difference in HIV-HCV coinfected patients? - Wikidata - awgldk - TriplyDB

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

http://www.wikidata.org/entity/Q43040362

about

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

http://www.wikidata.org/entity/Q43040362

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

@en

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

@nl

type

label

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

@en

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

@nl

prefLabel

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

@en

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

@nl

P1433

Q43040362-BEFBE50F-CAFF-4519-8AB3-51702796DD46

P1476

Q43040362-14D331F6-5C66-4932-BDAD-E0D04A31B3DF

P2093

Q43040362-CB2524C0-F679-4018-8F25-4E4456B859B5

P2860

Q43040362-02A0477C-D0E3-42F8-89F6-FB71D91DA65A

Q43040362-2EBE9F59-0F89-4405-8755-D29C27EFAE33

Q43040362-4503CD3E-6099-45B8-B78F-868DC04E0DE5

Q43040362-4B733113-8859-482E-8AF1-2299403F4756

Q43040362-58584862-AB4A-4EDA-A80C-78D0A81DE21B

Q43040362-9F050F68-D557-45C1-BFAF-EE664B86E10B

Q43040362-EF2B69F9-F3DB-403D-BDAF-B118494B0117

Q43040362-FFFA7A1A-B1B6-440B-9733-3F3FC7CDF6B4

P304

Q43040362-FBD8D8D3-67FD-42B8-A114-5A229374D6AC

P31

Q43040362-59412A15-ADDA-44B1-AFF4-6762707BCD36

Q43040362-6793f0d4-76ca-4ce2-9d74-da23a7129d28

P356

Q43040362-6BB3A5DC-DED7-478E-B3D9-EED067907148

P433

Q43040362-F93703A9-F6B7-4934-98C2-975A2A630A65

P478

Q43040362-3A46CC86-5AF1-42AF-80D1-A88751413AF7

P50

Q43040362-E3E1AE93-398B-4225-9A75-2270DEB5F06F

Q43040362-FA8B5B6C-8740-4490-AD45-50491DB112A9

P577

Q43040362-BF755925-5375-48D0-8317-2760ABE5A25B

P5875

Q43040362-59F42E35-DE9E-4BFE-B01F-364B72A63A2A

P698

Q43040362-72F31AEC-2FA5-44C6-B269-A3787BD0D1F0

P356

P1433

Expert Review of Anti-infective Therapy

P1476

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

@en

P2093

Stefano Fagiuoli

http://www.w3.org/2001/XMLSchema#string

P2860

Boceprevir for previously treated chronic HCV genotype 1 infection

Telaprevir for retreatment of HCV infection

Telaprevir for previously untreated chronic hepatitis C virus infection

Boceprevir for untreated chronic HCV genotype 1 infection

Replication of hepatitis C virus

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.

Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients.

P304

699-701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.11.85

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51637343

http://www.w3.org/2001/XMLSchema#string

P698

21905777

http://www.w3.org/2001/XMLSchema#string